Stage IV-S neuroblastoma. Results with definitive therapy

✍ Scribed by Steven H. Stokes; Patrick R. M. Thomas; Carlos A. Perez; Teresa J. Vietti

• Publisher: John Wiley and Sons
• Year: 1984
• Tongue: English
• Weight: 375 KB
• Volume: 53
• Category: Article
• ISSN: 0008-543X
• DOI: 10.1002/1097-0142(19840515)53:10<2083::aid-cncr2820531014>3.0.co;2-s

✦ Synopsis

The results of management of 14 patients with Stage IV-S neuroblastoma are reported. The treatment policy, although not consistent over this time span, in general used a combination of radiotherapy and chemotherapy or infrequently one modality alone. Twelve of 14 (86%) survived more than 6 years. One patient, with a solitary mediastinal primary tumor, died of rapidly progressive disease at three months. The other death occurred in a 4.5-year-old presenting with hepatomegaly a t diagnosis followed by skeletal dissemination 2.5 years later. Thirteen of the patients were younger than 1 year of age. Of the 11 patients that received radiotherapy, 4 experienced mild asymptomatic scoliosis or kyphoscoliosis a t 3 to 12 years after initial therapy. A review of the literature indicates that spontaneous regression in this tumor is very frequent; therefore, it is recommended that for the common presentation of massive hepatomegaly in an infant, close observation is warranted, unless life threatening complications occur. However, initial therapeutic intervention may be indicated in those patients with life threatening presentations. This data did not substantiate the necessity for complete surgical excision of the primary tumor, as has been suggested by others.